Literature DB >> 3736057

Seven cases of pelvic exenteration combined with sacral resection for locally recurrent rectal cancer.

H Takagi, T Morimoto, S Hara, R Suzuki, S Horio.   

Abstract

Local recurrence of rectal cancer following abdominoperineal resection is rarely amenable to limited resection. Carcinoembryonic antigen assay is valuable for diagnosing most recurrent rectal cancers, but it is inadequate for early detection. Pelvic computed tomography examination is very valuable for the early detection and localization of recurrence in relation to pelvic structures and can also serve as a guide in percutaneous needle biopsy of the tumor. Seven patients with deeply invading recurrent lesions underwent pelvic exenteration combined with sacral resection. The ileal segment conduit was used for ureteral urinary diversion. The mean operation time and blood loss were 8.8 hours and 6,200 ml, respectively. No operative deaths were encountered. One patient is alive 22 months postoperatively with no evidence of disease, and another patient is alive 32 months postoperatively with pelvic wall recurrence. This procedure seems a reasonable treatment for palliation and full recovery in certain patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3736057     DOI: 10.1002/jso.2930320314

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  Reresection for local recurrence of rectal cancer.

Authors:  W Adachi; A Nishio; H Watanabe; J Igarashi; K Yazawa; Y Nimura; N Koide; A Matsushita; T Monma; K Hanazaki; S Kajikawa; J Amano
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

Review 2.  Is total pelvic exenteration reasonable primary treatment for rectal carcinoma?

Authors:  L F Williams; C B Huddleston; J L Sawyers; J R Potts; K W Sharp; S W McDougal
Journal:  Ann Surg       Date:  1988-06       Impact factor: 12.969

3.  Composite resection of posterior pelvic malignancy.

Authors:  H J Wanebo; R J Koness; P S Turk; S I Cohen
Journal:  Ann Surg       Date:  1992-06       Impact factor: 12.969

4.  Pelvic resection of recurrent rectal cancer.

Authors:  H J Wanebo; R J Koness; M P Vezeridis; S I Cohen; D E Wrobleski
Journal:  Ann Surg       Date:  1994-10       Impact factor: 12.969

5.  Preliminary results of phase I trial of oral uracil/tegafur (UFT), leucovorin plus irinotecan and radiation therapy for patients with locally recurrent rectal cancer.

Authors:  Masayoshi Yasui; Masataka Ikeda; Mitsugu Sekimoto; Hirofumi Yamamoto; Ichiro Takemasa; Takafumi Ueda; Junzo Shimizu; Mutsumi Fukunaga; Osamu Suzuki; Takehiro Inoue; Morito Monden
Journal:  World J Surg Oncol       Date:  2006-11-22       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.